Company / CIK 0000730272
REPLIGEN CORP
- Ticker
- RGEN
- Size, estimated from filings
- Large cap ($10B – $200B)
- Insiders on file
- 15
- Members of Congress who traded it
- 1
- Federal contracts on record
- none matched
- Lobbying filings on record
- none matched
- SEC filings
- EDGAR ↗
- Latest trade on record
- October 6, 2026
REPLIGEN CORP (RGEN) has 15 insiders on file who disclosed 92 transactions in the last 12 months (0 open-market buys, 42 sales, about $23.8M at reported prices), and 3 congressional trades in its stock are on record. No federal contract award that started in the last 180 days was found for a recipient with exactly this name; no lobbying filing names it as client this year.
REPLIGEN CORP in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
8 people account for the disclosed buying and selling in REPLIGEN CORP over the last 12 months; the most active is Loeillot Olivier with $8.6M.
Insiders
| Name | Role | Rows | Bought | Sold | Last filed |
|---|---|---|---|---|---|
| Madaus Martin D | Interim CEO | 2 | 0 | 0 | October 23, 2026 |
| Douglass Brian Robb | CHIEF PRODUCT OFFICER | 6 | 0 | 2 | October 8, 2026 |
| Loeillot Olivier | Chief Executive Officer | 26 | 0 | 14 | October 6, 2026 |
| Garland Jason K | CFO | 7 | 0 | 5 | September 28, 2026 |
| Hughes Violetta | CHIEF ACCOUNTING OFFICER | 2 | 0 | 1 | September 2, 2026 |
| MUIR GLENN P | Director | 6 | 0 | 0 | May 18, 2026 |
| DAWES KAREN A | Director | 3 | 0 | 1 | May 18, 2026 |
| BARTHELEMY NICOLAS | Director | 2 | 0 | 0 | May 18, 2026 |
| Pax Margaret | Director | 2 | 0 | 0 | May 18, 2026 |
| EGLINTON MANNER CARRIE | Director | 2 | 0 | 0 | May 18, 2026 |
| Mhatre Rohin | Director | 2 | 0 | 0 | May 18, 2026 |
| Konstantinov Konstantin | Director | 2 | 0 | 0 | May 18, 2026 |
| Bylund James | Chief Operating Officer | 7 | 0 | 4 | March 23, 2026 |
| KURIYEL RALF | Senior VP, R&D | 6 | 0 | 3 | March 23, 2026 |
| Hunt Anthony | Director | 18 | 0 | 13 | March 3, 2026 |
Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.
Members of Congress who traded RGEN
From periodic transaction reports that name the company's stock. Amounts are the sums of the ranges as filed. Every row is on the RGEN page.
| Member | Seat | Trades | Bought | Sold | Range as filed | Latest |
|---|---|---|---|---|---|---|
| Lisa C. McClain | Representative (MI, District 9), Republican | 3 | 1 | 2 | $3,003–$45K | October 31, 2025 |
Insider transactions
| Filer | Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Douglass Brian Robb | RGEN | Other A | October 6, 2026 | October 8, 2026 | 2d | 675 | — | — | derivative | Form 4 ↗ | |
| Douglass Brian Robb | RGEN | Other A | October 6, 2026 | October 8, 2026 | 2d | 700 | — | — | Form 4 ↗ | ||
| Loeillot Olivier | RGEN | Option / conversion M | October 5, 2026 | October 6, 2026 | 1d | 4,202 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Sell S | October 5, 2026 | October 6, 2026 | 1d | 4,202 | $190 | $798K | 10b5-1 plan | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Option / conversion M | October 5, 2026 | October 6, 2026 | 1d | 4,202 | $155 | $651K | 10b5-1 plan | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Sell S | October 5, 2026 | October 6, 2026 | 1d | 1,333 | $179 | $238K | 10b5-1 plan | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Sell F | October 2, 2026 | October 5, 2026 | 3d | 1,248 | $182 | $227K | Form 4 ↗ | ||
| Garland Jason K | RGEN | Sell F | September 25, 2026 | September 28, 2026 | 3d | 421 | $190 | $80K | Form 4 ↗ | ||
| Loeillot Olivier | RGEN | Option / conversion M | September 24, 2026 | September 25, 2026 | 1d | 4,542 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Option / conversion M | September 24, 2026 | September 25, 2026 | 1d | 8,404 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Sell S | September 24, 2026 | September 25, 2026 | 1d | 4,542 | $190 | $863K | 10b5-1 plan | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Option / conversion M | September 24, 2026 | September 25, 2026 | 1d | 4,542 | $155 | $706K | 10b5-1 plan | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Sell S | September 24, 2026 | September 25, 2026 | 1d | 8,404 | $190 | $1.6M | 10b5-1 plan | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Option / conversion M | September 24, 2026 | September 25, 2026 | 1d | 8,404 | $155 | $1.3M | 10b5-1 plan | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Option / conversion M | September 21, 2026 | September 22, 2026 | 1d | 5,426 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Sell S | September 21, 2026 | September 22, 2026 | 1d | 5,426 | $180 | $977K | 10b5-1 plan | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Option / conversion M | September 21, 2026 | September 22, 2026 | 1d | 5,426 | $142 | $769K | 10b5-1 plan | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Sell S | September 4, 2026 | September 8, 2026 | 4d | 3,035 | $166 | $504K | 10b5-1 plan | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Sell F | September 3, 2026 | September 8, 2026 | 5d | 2,842 | $170 | $482K | late10b5-1 plan | Form 4 ↗ | |
| Hughes Violetta | RGEN | Sell F | September 1, 2026 | September 2, 2026 | 1d | 277 | $170 | $47K | Form 4 ↗ | ||
| Hughes Violetta | RGEN | Other A | March 5, 2026 | September 2, 2026 | 181d | 2,466 | — | — | late | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Option / conversion M | August 20, 2026 | August 21, 2026 | 1d | 5,426 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Sell S | August 20, 2026 | August 21, 2026 | 1d | 5,426 | $180 | $977K | 10b5-1 plan | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Option / conversion M | August 20, 2026 | August 21, 2026 | 1d | 5,426 | $142 | $769K | 10b5-1 plan | Form 4 ↗ | |
| Garland Jason K | RGEN | Sell S | July 16, 2026 | July 17, 2026 | 1d | 530 | $150 | $80K | 10b5-1 plan | Form 4 ↗ | |
| Garland Jason K | RGEN | Sell S | June 25, 2026 | June 26, 2026 | 1d | 733 | $145 | $106K | 10b5-1 plan | Form 4 ↗ | |
| Madaus Martin D | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 2,239 | — | — | derivative | Form 4 ↗ | |
| Madaus Martin D | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 995 | — | — | Form 4 ↗ | ||
| Konstantinov Konstantin | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 2,239 | — | — | derivative | Form 4 ↗ | |
| Konstantinov Konstantin | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 995 | — | — | Form 4 ↗ | ||
| Mhatre Rohin | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 2,239 | — | — | derivative | Form 4 ↗ | |
| Mhatre Rohin | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 995 | — | — | Form 4 ↗ | ||
| EGLINTON MANNER CARRIE | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 2,239 | — | — | derivative | Form 4 ↗ | |
| EGLINTON MANNER CARRIE | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 995 | — | — | Form 4 ↗ | ||
| Pax Margaret | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 2,239 | — | — | derivative | Form 4 ↗ | |
| Pax Margaret | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 995 | — | — | Form 4 ↗ | ||
| DAWES KAREN A | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 2,239 | — | — | derivative | Form 4 ↗ | |
| DAWES KAREN A | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 995 | — | — | Form 4 ↗ | ||
| MUIR GLENN P | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 2,239 | — | — | derivative | Form 4 ↗ | |
| MUIR GLENN P | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 995 | — | — | Form 4 ↗ | ||
| BARTHELEMY NICOLAS | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 2,239 | — | — | derivative | Form 4 ↗ | |
| BARTHELEMY NICOLAS | RGEN | Other A | May 14, 2026 | May 18, 2026 | 4d | 995 | — | — | Form 4 ↗ | ||
| MUIR GLENN P | RGEN | Option / conversion M | May 7, 2026 | May 8, 2026 | 1d | 2,434 | — | — | derivative | Form 4 ↗ | |
| MUIR GLENN P | RGEN | Option / conversion M | May 7, 2026 | May 8, 2026 | 1d | 2,434 | $39 | $94K | Form 4 ↗ | ||
| Douglass Brian Robb | RGEN | Sell F | May 7, 2026 | May 8, 2026 | 1d | 334 | $126 | $42K | Form 4 ↗ | ||
| Loeillot Olivier | RGEN | Sell S | April 21, 2026 | April 22, 2026 | 1d | 3,832 | $140 | $536K | 10b5-1 plan | Form 4 ↗ | |
| KURIYEL RALF | RGEN | Other A | March 5, 2026 | March 23, 2026 | 18d | 5,669 | — | — | latederivative | Form 4 ↗ | |
| KURIYEL RALF | RGEN | Other A | March 5, 2026 | March 23, 2026 | 18d | 5,284 | — | — | late | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Other A | March 5, 2026 | March 23, 2026 | 18d | 25,890 | — | — | latederivative | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Other A | March 5, 2026 | March 23, 2026 | 18d | 24,134 | — | — | late | Form 4 ↗ | |
| Bylund James | RGEN | Other A | March 5, 2026 | March 23, 2026 | 18d | 8,315 | — | — | latederivative | Form 4 ↗ | |
| Bylund James | RGEN | Other A | March 5, 2026 | March 23, 2026 | 18d | 7,751 | — | — | late | Form 4 ↗ | |
| Garland Jason K | RGEN | Other A | March 5, 2026 | March 23, 2026 | 18d | 8,315 | — | — | latederivative | Form 4 ↗ | |
| Garland Jason K | RGEN | Other A | March 5, 2026 | March 23, 2026 | 18d | 7,751 | — | — | late | Form 4 ↗ | |
| Bylund James | RGEN | Sell F | March 4, 2026 | March 5, 2026 | 1d | 62 | $126 | $7,802 | Form 4 ↗ | ||
| Bylund James | RGEN | Other A | March 4, 2026 | March 5, 2026 | 1d | 125 | — | — | Form 4 ↗ | ||
| KURIYEL RALF | RGEN | Sell F | March 4, 2026 | March 5, 2026 | 1d | 42 | $126 | $5,285 | Form 4 ↗ | ||
| KURIYEL RALF | RGEN | Other A | March 4, 2026 | March 5, 2026 | 1d | 125 | — | — | Form 4 ↗ | ||
| Bylund James | RGEN | Sell F | March 2, 2026 | March 3, 2026 | 1d | 2,433 | $125 | $304K | Form 4 ↗ | ||
| Bylund James | RGEN | Sell F | February 27, 2026 | March 3, 2026 | 4d | 1,478 | $129 | $190K | Form 4 ↗ | ||
| Loeillot Olivier | RGEN | Sell F | March 2, 2026 | March 3, 2026 | 1d | 1,610 | $125 | $201K | Form 4 ↗ | ||
| Loeillot Olivier | RGEN | Sell F | February 27, 2026 | March 3, 2026 | 4d | 344 | $129 | $44K | Form 4 ↗ | ||
| Hunt Anthony | RGEN | Sell F | March 2, 2026 | March 3, 2026 | 1d | 9,897 | $125 | $1.2M | Form 4 ↗ | ||
| Garland Jason K | RGEN | Sell F | March 2, 2026 | March 3, 2026 | 1d | 715 | $125 | $89K | Form 4 ↗ | ||
| Garland Jason K | RGEN | Sell F | February 27, 2026 | March 3, 2026 | 4d | 327 | $129 | $42K | Form 4 ↗ | ||
| KURIYEL RALF | RGEN | Sell F | March 2, 2026 | March 3, 2026 | 1d | 923 | $125 | $115K | Form 4 ↗ | ||
| KURIYEL RALF | RGEN | Sell F | February 27, 2026 | March 3, 2026 | 4d | 444 | $129 | $57K | Form 4 ↗ | ||
| Douglass Brian Robb | RGEN | Sell F | March 2, 2026 | March 3, 2026 | 1d | 221 | $125 | $28K | Form 4 ↗ | ||
| Douglass Brian Robb | RGEN | Other A | December 31, 2025 | January 12, 2026 | 12d | 2,143 | — | — | latederivative | Form 4 ↗ | |
| Douglass Brian Robb | RGEN | Other A | December 31, 2025 | January 12, 2026 | 12d | 2,288 | — | — | late | Form 4 ↗ | |
| DAWES KAREN A | RGEN | Sell S | December 17, 2025 | December 18, 2025 | 1d | 275 | $161 | $44K | Form 4 ↗ | ||
| MUIR GLENN P | RGEN | Option / conversion M | December 16, 2025 | December 17, 2025 | 1d | 3,366 | — | — | derivative | Form 4 ↗ | |
| MUIR GLENN P | RGEN | Option / conversion M | December 16, 2025 | December 17, 2025 | 1d | 3,366 | $26 | $88K | Form 4 ↗ | ||
| Hunt Anthony | RGEN | Other J | December 4, 2025 | December 8, 2025 | 4d | 2,000 | — | — | Form 4 ↗ | ||
| Loeillot Olivier | RGEN | Sell S | November 25, 2025 | November 26, 2025 | 1d | 7,041 | $170 | $1.2M | 10b5-1 plan | Form 4 ↗ | |
| Bylund James | RGEN | Sell S | November 18, 2025 | November 19, 2025 | 1d | 2,191 | $151 | $331K | Form 4 ↗ | ||
| Hunt Anthony | RGEN | Option / conversion M | November 13, 2025 | November 14, 2025 | 1d | 2,952 | — | — | derivative | Form 4 ↗ | |
| Hunt Anthony | RGEN | Option / conversion M | November 13, 2025 | November 14, 2025 | 1d | 2,952 | $34 | $100K | Form 4 ↗ | ||
| Hunt Anthony | RGEN | Sell S | November 13, 2025 | November 14, 2025 | 1d | 1,956 | $157 | $307K | Form 4 ↗ | ||
| Hunt Anthony | RGEN | Sell S | November 13, 2025 | November 14, 2025 | 1d | 5,737 | $156 | $896K | Form 4 ↗ | ||
| Hunt Anthony | RGEN | Sell S | November 13, 2025 | November 14, 2025 | 1d | 3,000 | $155 | $466K | Form 4 ↗ | ||
| Hunt Anthony | RGEN | Sell S | November 13, 2025 | November 14, 2025 | 1d | 2,500 | $154 | $386K | Form 4 ↗ | ||
| Hunt Anthony | RGEN | Sell S | November 13, 2025 | November 14, 2025 | 1d | 2,923 | $153 | $448K | Form 4 ↗ | ||
| Hunt Anthony | RGEN | Sell S | November 13, 2025 | November 14, 2025 | 1d | 2,100 | $152 | $320K | Form 4 ↗ | ||
| Hunt Anthony | RGEN | Sell S | November 13, 2025 | November 14, 2025 | 1d | 1,784 | $151 | $269K | Form 4 ↗ | ||
| Hunt Anthony | RGEN | Option / conversion M | November 12, 2025 | November 13, 2025 | 1d | 25,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hunt Anthony | RGEN | Sell S | November 12, 2025 | November 13, 2025 | 1d | 464 | $159 | $74K | 10b5-1 plan | Form 4 ↗ | |
| Hunt Anthony | RGEN | Sell S | November 12, 2025 | November 13, 2025 | 1d | 11,096 | $158 | $1.8M | 10b5-1 plan | Form 4 ↗ | |
| Hunt Anthony | RGEN | Sell S | November 12, 2025 | November 13, 2025 | 1d | 4,959 | $157 | $777K | 10b5-1 plan | Form 4 ↗ | |
| Hunt Anthony | RGEN | Sell S | November 12, 2025 | November 13, 2025 | 1d | 4,740 | $156 | $739K | 10b5-1 plan | Form 4 ↗ | |
| Hunt Anthony | RGEN | Sell S | November 12, 2025 | November 13, 2025 | 1d | 3,741 | $155 | $580K | 10b5-1 plan | Form 4 ↗ | |
| Hunt Anthony | RGEN | Option / conversion M | November 12, 2025 | November 13, 2025 | 1d | 25,000 | $34 | $847K | 10b5-1 plan | Form 4 ↗ | |
| Loeillot Olivier | RGEN | Sell F | October 2, 2025 | October 6, 2025 | 4d | 1,248 | $145 | $181K | Form 4 ↗ |
Federal contracts (USAspending, awards started in the last 180 days)
No contract award starting in the last 180 days was found for a recipient named exactly "REPLIGEN CORP". Subsidiaries and differently-spelled recipients are not matched — search contracts.
Lobbying (Senate LDA, as client)
No LDA filing posted since October 2025 names "REPLIGEN CORP" as the client. Filings under a subsidiary or trade-association name are not matched — search lobbying.
Related companies
Companies whose stock was traded by the same people who traded RGEN, by number of filers in common. It shows overlap in public filings and nothing else.
- UNITED THERAPEUTICS Corp UTHR 1 filer in common
- Dell Technologies Inc. DELL 1 filer in common
- Seagate Technology Holdings plc STX 1 filer in common
- Uber Technologies, Inc UBER 1 filer in common
- Datadog, Inc. DDOG 1 filer in common
- Arista Networks, Inc. ANET 1 filer in common
- Meta Platforms, Inc. META 1 filer in common
- Albertsons Companies, Inc. ACI 1 filer in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| House Clerk, periodic transaction reports | 1 | 3 | November 21, 2025 | November 21, 2025 | House Clerk search |
| SEC EDGAR, Form 4 | 43 | 93 | October 6, 2025 | October 8, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.
Not investment advice. Public records shown as filed; no recommendation is made or implied.